July 7, 2017 / 1:07 AM / 5 months ago

BRIEF-Compumedics cuts FY17 core earnings forecast

July 7 (Reuters) - Compumedics Ltd:

* Unaudited group FY17 EBITDA is expected to be between $2.1 million and $3.6 million before $1.6 million of one- off restructuring costs

* Restructuring activities in core capital equipment business resulted in lower than expected sales for twelve months to 30 June 2017 of about $33 mln

* “Expects us business to contribute strongly to overall group performance in FY18”

* “Company expects to remain cash flow positive” Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below